These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22396755)

  • 21. Implication of genetic variants in primary microRNA processing sites in the risk of multiple sclerosis.
    Hecker M; Fitzner B; Putscher E; Schwartz M; Winkelmann A; Meister S; Dudesek A; Koczan D; Lorenz P; Boxberger N; Zettl UK
    EBioMedicine; 2022 Jun; 80():104052. PubMed ID: 35561450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrative genomic analysis predicts novel functional enhancer-SNPs for bone mineral density.
    Qiu C; Shen H; Fu X; Xu C; Tian Q; Deng H
    Hum Genet; 2019 Feb; 138(2):167-185. PubMed ID: 30656451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comprehensive integrated post-GWAS analysis of Type 1 diabetes reveals enhancer-based immune dysregulation.
    Kim SS; Hudgins AD; Yang J; Zhu Y; Tu Z; Rosenfeld MG; DiLorenzo TP; Suh Y
    PLoS One; 2021; 16(9):e0257265. PubMed ID: 34529725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cells.
    Smets I; Fiddes B; Garcia-Perez JE; He D; Mallants K; Liao W; Dooley J; Wang G; Humblet-Baron S; Dubois B; Compston A; Jones J; Coles A; Liston A; Ban M; Goris A; Sawcer S
    Brain; 2018 Mar; 141(3):786-796. PubMed ID: 29361022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell- and stage-specific chromatin structure across the Complement receptor 2 (CR2/CD21) promoter coincide with CBF1 and C/EBP-beta binding in B cells.
    Cruickshank MN; Fenwick E; Karimi M; Abraham LJ; Ulgiati D
    Mol Immunol; 2009 Aug; 46(13):2613-22. PubMed ID: 19487031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple Functional Variants at 13q14 Risk Locus for Osteoporosis Regulate RANKL Expression Through Long-Range Super-Enhancer.
    Zhu DL; Chen XF; Hu WX; Dong SS; Lu BJ; Rong Y; Chen YX; Chen H; Thynn HN; Wang NN; Guo Y; Yang TL
    J Bone Miner Res; 2018 Jul; 33(7):1335-1346. PubMed ID: 29528523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bridging between Mouse and Human Enhancer-Promoter Long-Range Interactions in Neural Stem Cells, to Understand Enhancer Function in Neurodevelopmental Disease.
    D'Aurizio R; Catona O; Pitasi M; Li YE; Ren B; Nicolis SK
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Annotation of functional variation within non-MHC MS susceptibility loci through bioinformatics analysis.
    Briggs FB; Leung LJ; Barcellos LF
    Genes Immun; 2014 Oct; 15(7):466-76. PubMed ID: 25030428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart.
    He A; Kong SW; Ma Q; Pu WT
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5632-7. PubMed ID: 21415370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allele-specific transcriptional regulation of IRF4 in melanocytes is mediated by chromatin looping of the intronic rs12203592 enhancer to the IRF4 promoter.
    Visser M; Palstra RJ; Kayser M
    Hum Mol Genet; 2015 May; 24(9):2649-61. PubMed ID: 25631878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-range interactions between three transcriptional enhancers, active Vkappa gene promoters, and a 3' boundary sequence spanning 46 kilobases.
    Liu Z; Garrard WT
    Mol Cell Biol; 2005 Apr; 25(8):3220-31. PubMed ID: 15798207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic risk variants for multiple sclerosis are linked to differences in alternative pre-mRNA splicing.
    Putscher E; Hecker M; Fitzner B; Boxberger N; Schwartz M; Koczan D; Lorenz P; Zettl UK
    Front Immunol; 2022; 13():931831. PubMed ID: 36405756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility variants in the CD58 gene locus point to a role of microRNA-548ac in the pathogenesis of multiple sclerosis.
    Hecker M; Fitzner B; Blaschke J; Blaschke P; Zettl UK
    Mutat Res Rev Mutat Res; 2015; 763():161-7. PubMed ID: 25795118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms.
    Fransen NL; Crusius JBA; Smolders J; Mizee MR; van Eden CG; Luchetti S; Remmerswaal EBM; Hamann J; Mason MRJ; Huitinga I
    Brain Pathol; 2020 Jan; 30(1):106-119. PubMed ID: 31228212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.
    Ramagopalan SV; Maugeri NJ; Handunnetthi L; Lincoln MR; Orton SM; Dyment DA; Deluca GC; Herrera BM; Chao MJ; Sadovnick AD; Ebers GC; Knight JC
    PLoS Genet; 2009 Feb; 5(2):e1000369. PubMed ID: 19197344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRYAB promoter polymorphisms: influence on multiple sclerosis susceptibility and clinical presentation.
    Stoevring B; Frederiksen JL; Christiansen M
    Clin Chim Acta; 2007 Jan; 375(1-2):57-62. PubMed ID: 17010329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leveraging three-dimensional chromatin architecture for effective reconstruction of enhancer-target gene regulatory interactions.
    Salviato E; Djordjilović V; Hariprakash JM; Tagliaferri I; Pal K; Ferrari F
    Nucleic Acids Res; 2021 Sep; 49(17):e97. PubMed ID: 34197622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility.
    Zuvich RL; McCauley JL; Oksenberg JR; Sawcer SJ; De Jager PL; ; Aubin C; Cross AH; Piccio L; Aggarwal NT; Evans D; Hafler DA; Compston A; Hauser SL; Pericak-Vance MA; Haines JL
    Hum Genet; 2010 Mar; 127(5):525-35. PubMed ID: 20112030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From genetic associations to functional studies in multiple sclerosis.
    Bos SD; Berge T; Celius EG; Harbo HF
    Eur J Neurol; 2016 May; 23(5):847-53. PubMed ID: 26948534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A factor known to bind to endogenous Ig heavy chain enhancer only in lymphocytes is a ubiquitously active transcription factor.
    Elmaleh N; Matthias P; Schaffner W
    Eur J Biochem; 1990 Feb; 187(3):507-13. PubMed ID: 2105887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.